07/21/2015

Myeloma paper published in NMED

Dr Sarah Bond from Cambridge Biomedical is co-author of myeloma paper  "NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma" published in NMED

 

http://www.nature.com/nm/journal/vaop/ncurrent/full/nm.3910.html


 

  
Latest News   

 Subscribe to our blog

For existing clients & test results please contact 
Customer Service:617.456.0800
All rights reserved. Cambridge Biomedical, the Cambridge Biomedical logo, Science and Service, and Custom
Solutions for Life Sciences Companies are registered or unregistered trademarks of Cambridge Biomedical Inc.
|     Privacy Statement     | Terms of Use